Quality Level
grade
certified reference material, pharmaceutical secondary standard
agency
traceable to Ph. Eur. Y0000297, traceable to USP 1392705
API family
mesalamine, mesalazine
CofA
current certificate can be downloaded
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
mp
275-280 °C (dec.) (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-30°C
SMILES string
Nc1ccc(O)c(c1)C(O)=O
InChI
1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)
InChI key
KBOPZPXVLCULAV-UHFFFAOYSA-N
Gene Information
human ... ALOX5(240), PPARG(5468), PTGS1(5742), PTGS2(5743)
General description
美沙拉嗪是一种结构与水杨酸盐类似的药物。它具有消炎活性,并作为一种使用广泛的药物用于治疗炎症性肠病,包括溃疡性直肠炎和′克罗恩病。
用于质量控制的药品二级标准品,为制药实验室和制造商制备内部工作标准品,提供了一种方便且高性价比的替代方案。
用于质量控制的药品二级标准品,为制药实验室和制造商制备内部工作标准品,提供了一种方便且高性价比的替代方案。
Application
美沙拉嗪可用作药物参考标准品,用于通过分光光度技术测定药物制剂中的分析物。
5-氨基水杨酸是适用于ELISA分析的过氧化物酶底物。这一底物产生可溶性的棕色终产物,可在450nm处通过分光光度法读取。使用3 N NaOH可终止反应并在550 nm处读取结果。
这些二级标准品是 合格的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。
Analysis Note
These secondary standards offer multi-traceability to the USP and EP primary standards, where they are available.
Other Notes
要查看该材料的分析证书示例,请在下面的栏位中输入LRAA7131。这只是一个示例证书,可能不是您收到的批次。
该认证参考物质(CRM)根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。
Still not finding the right product?
Explore all of our products under 氨水杨酸
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
flash_point_f
No data available
flash_point_c
No data available
Spectrophotometric methods for the determination of mesalamine in bulk and pharmaceutical dosage forms
Acharjya KS, et al.
Journal of Pharmaceutical Education and Research, 1(1), 63-63 (2010)
Development and validation of UV spectrophotometric method for the determination of mesalamine in bulk and tablet formulation
Moharana KA, et al.
International Journal of Pharmacy and Pharmaceutical Sciences, 3(2), 19-21 (2011)
Urpo Nieminen et al.
International journal of cancer, 134(1), 189-196 (2013-06-26)
Patients with long-standing inflammatory bowel disease (IBD) have an increased risk for colorectal carcinoma (CRC). Earlier studies suggest that the severity of inflammation is an independent risk factor for CRC in ulcerative colitis (UC). We investigated the role of histological
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| PHR1060-1G | 04061835237258 |
